Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- SENTENCE label "Based on these findings, dexamethasone (Dex)-target complexes were used to perform MD simulations to analyze dexamethasone (Dex) stability at 50 ns." provenance.
- SENTENCE label "Based on these findings, dexamethasone (Dex)-target complexes were used to perform MD simulations to analyze dexamethasone (Dex) stability at 50 ns." provenance.
- SENTENCE label "Based on these findings, dexamethasone (Dex)-target complexes were used to perform MD simulations to analyze dexamethasone (Dex) stability at 50 ns." provenance.
- SENTENCE label "Based on these findings, dexamethasone (Dex)-target complexes were used to perform MD simulations to analyze dexamethasone (Dex) stability at 50 ns." provenance.
- SENTENCE label "The therapeutic effect of dexamethasone may be related to dexamethasone's ability to improve cortical function." provenance.
- SENTENCE label "The therapeutic effect of dexamethasone may be related to dexamethasone's ability to improve cortical function." provenance.
- SENTENCE label "The therapeutic effect of dexamethasone may be related to dexamethasone's ability to improve cortical function." provenance.
- SENTENCE label "The therapeutic effect of dexamethasone may be related to dexamethasone's ability to improve cortical function." provenance.
- SENTENCE label "The therapeutic effect of dexamethasone may be related to dexamethasone's ability to improve cortical function." provenance.
- SENTENCE label "The therapeutic effect of dexamethasone may be related to dexamethasone's ability to improve cortical function." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with diabetes mellitus (DM) and coronavirus disease 2019 (COVID)-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS)-CoV-2)." provenance.
- SENTENCE label "A low-middle dose of dexamethasone and heparin seems to be effective in COVID-19 patients, but data regarding A low-middle dose of dexamethasone and heparin's possible efficacy in viral pneumonia caused by other viruses are conflicting." provenance.
- SENTENCE label "A low-middle dose of dexamethasone and heparin seems to be effective in COVID-19 patients, but data regarding A low-middle dose of dexamethasone and heparin's possible efficacy in viral pneumonia caused by other viruses are conflicting." provenance.
- SENTENCE label "A low-middle dose of dexamethasone and heparin seems to be effective in COVID-19 patients, but data regarding A low-middle dose of dexamethasone and heparin's possible efficacy in viral pneumonia caused by other viruses are conflicting." provenance.
- SENTENCE label "A low-middle dose of dexamethasone and heparin seems to be effective in COVID-19 patients, but data regarding A low-middle dose of dexamethasone and heparin's possible efficacy in viral pneumonia caused by other viruses are conflicting." provenance.
- SENTENCE label "A low-middle dose of dexamethasone and heparin seems to be effective in COVID-19 patients, but data regarding A low-middle dose of dexamethasone and heparin's possible efficacy in viral pneumonia caused by other viruses are conflicting." provenance.
- SENTENCE label "Compared to standard care, remdesivir for both 5 and 10 days, lopinavir/ritonavir, and dexamethasone reduced the risk of any severe AEs by 52% (0.48, 0.34–0.67), 24% (0.77, 0.63–0.92), 40% (0.60, 0.37–0.98), and 50% (0.50, 0.25–0.98) respectively." provenance.
- SENTENCE label "Compared to standard care, remdesivir for both 5 and 10 days, lopinavir/ritonavir, and dexamethasone reduced the risk of any severe AEs by 52% (0.48, 0.34–0.67), 24% (0.77, 0.63–0.92), 40% (0.60, 0.37–0.98), and 50% (0.50, 0.25–0.98) respectively." provenance.
- SENTENCE label "Compared to standard care, remdesivir for both 5 and 10 days, lopinavir/ritonavir, and dexamethasone reduced the risk of any severe AEs by 52% (0.48, 0.34–0.67), 24% (0.77, 0.63–0.92), 40% (0.60, 0.37–0.98), and 50% (0.50, 0.25–0.98) respectively." provenance.
- SENTENCE label "Compared to standard care, remdesivir for both 5 and 10 days, lopinavir/ritonavir, and dexamethasone reduced the risk of any severe AEs by 52% (0.48, 0.34–0.67), 24% (0.77, 0.63–0.92), 40% (0.60, 0.37–0.98), and 50% (0.50, 0.25–0.98) respectively." provenance.
- SENTENCE label "Compared to standard care, remdesivir for both 5 and 10 days, lopinavir/ritonavir, and dexamethasone reduced the risk of any severe AEs by 52% (0.48, 0.34–0.67), 24% (0.77, 0.63–0.92), 40% (0.60, 0.37–0.98), and 50% (0.50, 0.25–0.98) respectively." provenance.